| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/02/2008 | EP1938814A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 07/02/2008 | EP1937656A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as beta 2 adrenoceptor agonists |
| 07/02/2008 | EP1937652A1 Pyrimidine amide compounds as pgds inhibitors |
| 07/02/2008 | EP1937633A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 07/02/2008 | EP1937267A2 M3 muscarinic acetylcholine receptor antagonists |
| 07/02/2008 | EP1937250A2 Ligustilide derivatives for the treatment of inflammatory disorders |
| 07/02/2008 | EP1937238A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 07/02/2008 | EP1937231A1 Pharmaceutical compositions for the treatment of chronic obstructive pulmonary disease |
| 07/02/2008 | EP1937230A2 M3 muscarinic acetylcholine receptor antagonists |
| 07/02/2008 | EP1567140B1 Synergistic combination comprising roflumilast and (r,r)-formoterol |
| 07/02/2008 | EP1567139B1 New synergistic combination comprising roflumilast and formoterol |
| 07/02/2008 | EP1533313B1 Novel flavone c-glycoside derivatives and composition containing the derivatives |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1451181B1 Dimeric compounds and their use as anti-viral agents |
| 07/02/2008 | EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | CN101213187A Isoquinoline derivatives as inhibitors of RHO-kinase |
| 07/02/2008 | CN101212961A HMB compositions and uses thereof |
| 07/02/2008 | CN101209364A Medical tetrad therapy |
| 07/02/2008 | CN101209348A Elastic nano vesicle carrier and preparation and application thereof |
| 07/02/2008 | CN101209341A Chinese medicinal preparation, preparation and quality control method thereof |
| 07/02/2008 | CN101209339A Wax candle with incense treating function and preparation method thereof |
| 07/02/2008 | CN101209334A Lung cancer-treating medicament and preparation thereof |
| 07/02/2008 | CN101209333A Chinese medicinal granule for animals with cough and asthma relieving efficacy |
| 07/02/2008 | CN101209329A Chinese medicinal oral liquid with heat-clearing and detoxication, lung-heat-clearing and cough-relieving efficacy |
| 07/02/2008 | CN101209320A Chinese medicinal granule with heat-clearing and detoxication, hydrops-eliminating and mass-dissipating efficacy |
| 07/02/2008 | CN101209316A Chinese medicinal injection with heat-clearing and detoxication, cough and asthma relieving efficacy |
| 07/02/2008 | CN101209311A Chinese medicinal injection with heat-clearing and detoxication, detumescence and mass-dissipating efficacy |
| 07/02/2008 | CN101209302A Heat-clearing and detoxication traditional Chinese medicine preparation and preparation thereof |
| 07/02/2008 | CN101209298A Chinese medicinal granule for treating infectious rhinitis of avian |
| 07/02/2008 | CN101209294A Chinese medicinal granule for animals with cough and asthma relieving efficacy |
| 07/02/2008 | CN101209293A Chinese medicinal granule with heat-clearing, detoxication, wind-expelling and cold-expelling efficacy |
| 07/02/2008 | CN101209283A 'Yinhuanghanhua' dropping pill for treating upper respiratory tract infection |
| 07/02/2008 | CN100398653C Novel streptococcus antigens |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/02/2008 | CN100398136C Medicated pendant for preventing and treating common cold |
| 07/02/2008 | CN100398116C Medicine for treating stomatocase and laryngopharyngitis |
| 07/02/2008 | CN100398101C Use of pbromophenacylbromide in preparing medicament for preventing and/or treating asthma |
| 07/02/2008 | CN100398094C Formoterol superfine formulation |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393854 Respiratory system disorders; asthma |
| 07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393544 Microstructures containing a drug and a suspension medium that permeates into the permeable microstructures; density variations between suspended particles and medium are minimized and attractive forces between microstructures are attenuated, resulting in settling and flocculation resistance |
| 07/01/2008 | US7393535 Adjuvants for use in vaccines |
| 06/26/2008 | WO2008076321A1 Engineered anti-tslp antibody |
| 06/26/2008 | WO2008076265A1 MONOPHOSPHATES AS MUTUAL PRODRUGS OF ANTI-INFLAMMATORY SIGNAL TRANSDUCTION MODULATORS (AISTM'S) AND β-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION |
| 06/26/2008 | WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | WO2008075978A2 An extract |
| 06/26/2008 | WO2008075713A1 Marker for diagnosis of cancer, and target molecule for therapy |
| 06/26/2008 | WO2008075706A1 Therapeutic agent for interstitial pneumonia |
| 06/26/2008 | WO2008075104A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 06/26/2008 | WO2008075025A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | WO2008075005A1 Quinuclidinol derivatives as muscarinic receptor antagonists |
| 06/26/2008 | WO2008074856A1 Combination therapy for the treatment of airways disease |
| 06/26/2008 | WO2008074227A1 Synthetic ion channels |
| 06/26/2008 | WO2008036387A8 Method of treating endothelial dysfunction |
| 06/26/2008 | US20080153917 Sigma Receptor Ligands |
| 06/26/2008 | US20080153855 Chemical Compounds |
| 06/26/2008 | US20080153833 Substituted pteridines for the treatment of inflammatory diseases |
| 06/26/2008 | US20080153744 Novel cyclosporin alkynes and their utility as pharmaceutical agents |
| 06/26/2008 | US20080153743 Methods relating to the treatment of fibrosis |
| 06/26/2008 | US20080152623 Using expression vector comprising nucleotide sequences coding secreted protease inhibitor domain proteins as therapeutic tool in treatment of obstructive respiratory disorders |
| 06/26/2008 | US20080149097 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2672983A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 06/26/2008 | CA2672792A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | CA2672446A1 Quinuclidinol derivatives as muscarinic receptor antagonists |
| 06/26/2008 | CA2672257A1 Method for improving ventilatory efficiency |
| 06/26/2008 | CA2671668A1 Therapeutic composition for interstitial pheumonia |
| 06/26/2008 | CA2671538A1 Engineered anti-tslp antibody |
| 06/26/2008 | CA2670730A1 Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (aistm's) and beta-agonists for the treatment of pulmonary inflammation and bronchoconstriction |
| 06/25/2008 | EP1935892A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1935425A2 Immunemodulating oligosaccharides for the treatment and/or prevention of chronic obstructive pulmonary disease (COPD) |
| 06/25/2008 | EP1934219A1 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| 06/25/2008 | EP1934184A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists |
| 06/25/2008 | EP1934181A2 Kinase inhibitors |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933847A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 06/25/2008 | EP1933846A2 Compositions comprising phosphatidic acid for treatment of eosinophilia and related disorders |
| 06/25/2008 | EP1933842A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 06/25/2008 | EP1933834A1 Benzoxazoles useful in the treatment of inflammation |
| 06/25/2008 | EP1933831A2 Modulators of atp-binding cassette transporters |
| 06/25/2008 | EP1933828A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 06/25/2008 | EP1725552B1 New quaternized quinuclidine esters |
| 06/25/2008 | EP1718336B1 Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases |
| 06/25/2008 | EP1492499B1 Formoterol and mometasone aerosol formulations |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1377164B1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/25/2008 | EP1322321B1 Use of S-[2,3-Bispalmitoyloxy-(2RS)-propyl]cysteinyl-GNNDESNISFKEK (MALP-2) |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208304A Quinoline 3-sulfonate esters as NK3 receptor modulators |
| 06/25/2008 | CN101204569A Composite for pneumonia |